Experimental Hormone Reduces Visceral Fat in HIV Patients - CME Teaching Brief® - MedPage Today

CROI: Experimental Hormone Reduces Visceral Fat in HIV Patients - CME Teaching Brief® - MedPage Today: "LOS ANGELES, Feb. 27 -- An experimental synthetic hormone significantly reduces visceral fat in patients treated for HIV, Harvard researcher said here.

Compared with placebo, the growth hormone releasing analog TH9507 reduced visceral fat by about 20%, Steven Grinspoon, M.D., of Harvard Medical School, and colleagues, reported at the annual Conference on Retroviruses and Opportunistic Infections. "